Cargando…
The Impact of Substantial Improvements in HbA1c and Weight Loss on the Medication Preferences of People with Type 2 Diabetes
PURPOSE: To quantify the preferences of people with type 2 diabetes (T2D) for treatment attributes of a glucose-dependent insulinotropic polypeptide (GIP)/glucagon-like peptide-1 (GLP-1) receptor agonist (RA) versus an injectable GLP-1 RA medication profile. PATIENTS AND METHODS: Injection-naive peo...
Autores principales: | Gelhorn, Heather L, Osumili, Beatrice, Brown, Katelyn, Ross, Melissa M, Schulz, Andrea, Fernandez, Gabriela, Boye, Kristina S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040168/ https://www.ncbi.nlm.nih.gov/pubmed/36987498 http://dx.doi.org/10.2147/PPA.S401465 |
Ejemplares similares
-
Patients' preferences for once‐daily oral versus once‐weekly injectable diabetes medications: The REVISE study
por: Boye, Kristina, et al.
Publicado: (2020) -
The Benefits of Safely Achieving Near Normoglycemia from the Perspective of People with Type 2 Diabetes: A Quantitative Survey Study
por: Gelhorn, Heather L, et al.
Publicado: (2022) -
Estimating meaningful change for The Impact of Weight on Self-Perception (IW-SP) questionnaire among people with type 2 diabetes
por: Gelhorn, Heather L., et al.
Publicado: (2023) -
The Association Between Sustained HbA1c Control and Long-Term Complications Among Individuals with Type 2 Diabetes: A Retrospective Study
por: Boye, Kristina S., et al.
Publicado: (2022) -
Feasibility study of portable technology for weight loss and HbA1c control in type 2 diabetes
por: Bentley, Claire L., et al.
Publicado: (2016)